发明名称 |
MEDICAL DEVICE |
摘要 |
The present invention relates to the use of a gene transfer product to reduce hyperplastic connective tissue growth after tissue trauma or implantation of a medical device. The present invention also relates to a medical device with improved biological properties for an at least partial contact with blood, bodily fluids and/or tissues when introduced in a mammalian body, which device comprises a core and a nucleic acid, encoding a product capable of leading to production of extracellular superoxide dismutase present in a biologically compatible medium. Said nucleic acid encodes a translation or transcription product, which is capable of inhibiting hyperplastic connective tissue growth and promoting endothelialisation in vivo at least partially on a synthetic surface of said core. The present invention also relates to a method of producing a medical device according to the invention. |
申请公布号 |
EP1385537(A1) |
申请公布日期 |
2004.02.04 |
申请号 |
EP20020731043 |
申请日期 |
2002.04.30 |
申请人 |
FIT BIOTECH OYJ PLC |
发明人 |
LAHTINEN, MIKA;LAUKKANEN, MIKKO;YLA-HERTTUALA, SEPPO;LEPPAENEN, OLLI-PEKKA |
分类号 |
A61L31/00;A61F2/06;A61F2/82;A61F2/84;A61K38/44;A61L27/00;A61L33/00;(IPC1-7):A61K38/44;A61F2/00 |
主分类号 |
A61L31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|